Molecule to Medicine
PrivateCompany Overview
Molecule to Medicine is a biotechnology venture builder and innovation ecosystem that co-creates and scales drug discovery companies using a pod-based model.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
biotech venture builderbiotech incubatordrug discoverybioinformatics platformbiotech startup studiotherapeutic developmentbiomarker discoverypreclinical developmentcomputational biologytarget identificationbiotech venturelife science startup
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule to Medicine Comparables
Compare Molecule to Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syncona | 78% | |
| Evotec | 73% | |
| Apollo Health Ventures | 73% | |
Molecule to Medicine Funding Rounds
Historical fundraising activity
Molecule to Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Molecule to Medicine's valuation, stock price, and market status.